AIPSMP Alergomed EOOD
- Address
- 11 Saborni Str., 9000 Varna, Bulgaria
AIPSMP Alergomed EOOD - Respiratory and Allergy Research Center
AIPSMP Alergomed EOOD is a specialized clinical research center focused on respiratory diseases and allergic conditions. The center demonstrates particular expertise in conducting advanced pharmaceutical trials for patients with complex moderate-to-severe asthma who remain uncontrolled despite standard therapeutic interventions.
- Phase 2a trials for novel asthma therapeutics in patients uncontrolled on medium-high dose ICS-LABA combinations
- Evaluation of emerging bronchodilator and anti-inflammatory agents for respiratory conditions
- Clinical efficacy and safety assessments in adult populations with challenging-to-treat asthma phenotypes
The center's research portfolio emphasizes the development of innovative treatment strategies for patients who fail to achieve adequate disease control with inhaled corticosteroid-long-acting beta-agonist (ICS-LABA) therapy. AIPSMP Alergomed EOOD provides comprehensive clinical trial management with focus on pulmonary function monitoring, symptom control assessment, and safety evaluation in respiratory medicine studies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in AIPSMP Alergomed EOOD
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of AZD4604 in Adults with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA | AstraZeneca AB | Phase II | Not Recruiting | Sep 2024 | Jun 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| (2R)-N-[3-(5-Fluoro-2-{[2-Fluoro-3-(Methylsulfonyl)Phenyl]Amino}-4-Pyrimidinyl)-1H-Indol-7-Yl]-3-Methoxy-2-(4-Methyl-1-Piperazinyl)Propanamide-1-Hydroxy-2-Naphthoic Acid | 1 | Unknown | 2024-09-26 | 2024-09-26 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.